Glen Allen, VA, United States of America

Andrew K Ottens

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Banyan Biomarkers, Inc., University of Florida Research Foundation Inc.. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew K Ottens. Retrieved from https://idiyas.com/inventor/andrew-k-ottens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0



Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Gainesville, FL (US) (2010)
  • Glen Allen, VA (US) (2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andrew K. Ottens

Introduction

Andrew K. Ottens is a notable inventor based in Glen Allen, Virginia. He has made significant contributions to the field of biomedical research, particularly in the area of traumatic brain injury and liver diagnostics. With a total of 2 patents, his work has the potential to impact clinical practices and improve patient outcomes.

Latest Patents

Ottens' latest patents include groundbreaking research on biomarkers for traumatic brain injury. His work on "Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury" reveals that collapsin response mediator proteins (CRMPs) decrease in tissue and increase in biological fluids following neural injury from traumatic brain injury (TBI). Significant decreases of CRMP1, CRMP2, CRMP4, and CRMP5 were observed, accompanied by the appearance of distinct breakdown products from proteolytic cleavage by calpain. Additionally, synaptotagmin breakdown products were associated with TBI and could be detected in human cerebral spinal fluid (CSF). Both biomarkers were found in human biofluid and related to recovery from traumatic brain injury. Another patent focuses on "Biomarkers of liver injury," which provides novel, sensitive, and specific markers for diagnosing and monitoring liver injuries, including ischemic liver damage. This includes the identification of several enzymes related to the arginine/urea/nitric oxide cycle, sulfuration enzymes, and spectrin breakdown products.

Career Highlights

Throughout his career, Andrew K. Ottens has worked with various organizations, including Banyan Biomarkers, Inc. and the University of Florida Research Foundation. His research has been pivotal in advancing the understanding of biomarkers related to brain and liver injuries.

Collaborations

Ottens has collaborated with notable individuals in his field, including Ronald L. Hayes and Monika Oli. Their combined expertise has contributed to the success of his research endeavors.

Conclusion

Andrew K. Ottens is a distinguished inventor whose work in biomarker research has the potential to transform diagnostics and treatment for traumatic brain injury and liver conditions. His contributions are invaluable to the medical community and continue to pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…